Cardiovascular diseases (CVDs) are the leading cause of death globally, claiming around 17.9 million lives each year. Heart attacks and strokes are responsible for more than 80% of these deaths, with one-third occurring in individuals under 70. Understanding your genetic predisposition to these conditions can be life-saving.
Understanding the Comprehensive Cardiology Panel
Our Comprehensive Cardiology Panel is designed to uncover the genetic factors contributing to major cardiovascular disorders. By leveraging advanced sequencing technologies and sophisticated variant analysis algorithms, this panel provides critical insights that are essential for:
- Identifying At-Risk Individuals: Early detection of genetic variants linked to heart conditions.
- Accurate Diagnoses: Precise identification of cardiovascular disorders at a genetic level.
- Predicting Disease Progression: Understanding how genetic factors influence the course of the disease.
- Assessing Prognosis: Evaluating long-term outcomes based on genetic findings.
- Guiding Personalized Treatment: Tailoring interventions to the individual‘s genetic makeup.
Conditions Covered
| Aortic aneurysm, hereditary thoracic panel | Catecholaminergic polymorphic ventricular tachycardia panel |
| Arrhythmia | Congenital heart defects |
| Arrhythmogenic Right Ventricular Cardiomyopathy | Familial hypercholesterolemia |
| Brugada syndrome | Heterotaxy |
| Cardiomyopathy dilated panel | Hypertrophic Cardiomyopathy |
Individual conditions are also offered
Clinical Utility of the Comprehensive Cardiology Panel
The Comprehensive Cardiology Panel offers numerous clinical benefits:
- Accurate Diagnosis: Identifies specific genetic variants associated with heart conditions, leading to precise diagnoses.
- Risk Assessment and Prognosis: Detects genetic variants that increase cardiovascular risk, enabling early identification and proactive monitoring.
- Family Screening and Genetic Counseling: Supports family screening, allowing for informed risk assessments and family planning.
- Research and Advancements: Contributes to ongoing research in cardiovascular genetics, fostering new discoveries.
- Personalized Care: Facilitates tailored interventions and preventive strategies based on individual genetic profiles.
- Improved Patient Outcomes: Enhances patient care through accurate diagnoses and proactive risk management.
Test specification
| Technique | Coverage | Variant types | TAT | Sample requirements |
|---|---|---|---|---|
| NGS | 150 - 180X | SNP | 3 - 4 weeks | 2 ml EDTA Blood / 2 ug DNA |